Cover Image

ADVERSE DRUG REACTION PATTERN OF ANTI-ASTHMATIC DRUGS PRESCRIBED IN ASTHMA OUT-PATIENT DEPARTMENT IN A TERTIARY CARE HOSPITAL

NARENDRA BABU S SADHASIVAM

Abstract


PATTERN AND SEVERITY OF ADVERSE
DRUG REACTION OF ANTI-ASTHMATIC
DRUGS PRESCRIBED IN MEDICINE
OUTPATIENT DEPARTMENT IN A TERTIARY
CARE HOSPITAL OBJECTIVE To
study the pattern and severity of adverse
drug reactions of anti-asthmatic drugs in
patients attending Medicine out- patient
department in a tertiary care hospital.
METHODOLOGY The study was conducted
in adult patients with Bronchial
Asthma attending Asthma outpatient of a
tertiary care hospital between August 2013
to October 2013. Study period was 3
months. Sample size was 500. After getting
approval from the Institutional Human
ethics committee, 794 prescriptions were
screened, 500 prescriptions that met the
inclusion criteria were chosen for analysis.
Adverse Drug Reactions (ADR) were
documented in WHO ADR reporting form.
Causality assessment of the ADR was
done by WHO causality assessment scale.
Severity was assessed using
Modified Hartwig Siegel severity assessment
scale.RESULTS Most of the patients
were in the age group of 61-70 years.
Males constituted 34 percentage and females
66 percentage. Beta 2 agonists
were the most commonly prescribed antiasthmatic
drug group. Adverse Drug Reactions
were more common in elderly females.
Tremor was the most common Adverse
Drug Reaction encountered. Most
of the ADR comes under possible category
of WHO causality assessment scale
and were mild.CONCLUSION Beta 2 agonists
were the most commonly prescribed
anti asthmatic drug group. 34 percentage
of patients encountered Adverse Drug Reactions.
Adverse Drug Reactions were
more common in elderly females. Tremor
was the most common Adverse Drug Reaction
encountered. Most of ADRs were
mild and comes under possible category
of WHO causality assessment scale.

 


Full Text:

PDF

References


Harrison EB, Stephen HL, Dan FL,

Dennis KL, Larry JJ. Harrison’s principle

of internal medicine. 2001;2:1456–505.

Masoli M, Fabian D, Holt S, Beasley

R. Global burden of asthma. Developed

for the Global initiative for asthma. 2004;

-3.

World health reports 2001. Fifty facts

from the world health report 1998:

Global Health Situation and Trends

-2025. WHO. 2001

Murray CJ, Lopez AD. Global mortality,

disability and the contribution of

risk factors: Global burden of disease

study. Lancet. 1997; 349:1436–42.

National commission on Macroeconomics

and health- Burden of disease

in India. 2005;251:63.

Stock S, Redaelli M, Luengen M,

Wendland G, Civello D, Lauterbach

KW: Asthma: prevalence and cost of

illness. European Respiratory Journal.

; 25: 247-53.

Geneva: World Health organization.

WHO. Requirements for adverse drug

reaction reporting. 1975; 1039–109.

Gross F. Drug utilization therapy

and practice. The present situation in

the Federal Republic of Germany.

European Journal Clinical Pharmacology

;19:387-94.

Stolley PD, Lasagna L. Prescribing

patterns of physicians. Journal of

chronic diseases 1969; 22:395-405.

JAMA 1998; 279: 1200-1205

Udomratn P, Lin KM, Singh BS,

Chui E, editors. Outpatient prescribing

practices in Asian Countries.

Ethno-psychopharmacology: Advances

in current practice. Cambridge:

Cambridge University Press,

: 135-143.

Uppsala Monitoring Centre (2006),

the use of the World Health Organization-

Uppsala Monitoring Centre

(WHO-UMC) system for standardised

case causality assessment. Accessed

f r o m : h t t p : / / w h o - u m c . o r g /

graphics/4409.pdf. 2012

Hartwig SC, Siegel J, Schneider PJ.

Preventability and severity assessment

in reporting adverse drug reactions. Am

J Hosp Pharm. 1992;49:2229–32.

Kallergis EM, Manios EG, Kanoupakis

EM, Schiza SE, Mavrakis HE,

Klapsinos NK, et al. Acute electrophysiologic

effects of inhaled salbutamol in

humans. Chest. 2005;127: 2057–63.

Bajaj A, Balakrishna S, Sawarkar S.

Assessment of therapeutic performances

of inhalation aerosols and clinical

pharmacist’s services in PFT lab. Indian

J Hosp Pham. 1999; 36:138–42.

Carter WJ et al, Selective beta2 agonists

– side effects". British National Formulary

th edition. London: BMJ Publishing

Group Ltd and Royal Pharmaceutical

Society publishing, 2008.

Kaminstein, David. "Steroid withdrawal".

Medicinenet. 23 December


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An Initiative of The Tamil Nadu Dr M.G.R. Medical University